Awareness of Emerging Novel Epigenetic Targeting Therapy in Acute Myeloid Leukemia

Cancer therapy & Oncology International Journal
doi 10.19080/ctoij.2018.11.555815
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?

Therapeutic Advances in Hematology
Hematology
2019English

The Epigenetic Landscape of Acute Myeloid Leukemia

Advances in Hematology
Hematology
2014English

Emerging Therapies for Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Therapy of Acute Myeloid Leukemia

2012English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

Can Novel Genetic Polymorphisms Predict Response to Therapy in Acute Myeloid Leukemia?

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2010English

Increased Anti-Leukemic Activity of Decitabine via AR-42-induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

Seminars in Oncology
OncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy